Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.

20-Mar-2020 - Germany

Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.

Koki Holdings will focus on developing its position as a comprehensive provider of power tools aiming to become a leading global company through strategic investment, accelerated technology and product development.

“We are excited to acquire Koki’s centrifuge business and its premium himac brand. These high-performance products are an ideal fit for Eppendorf's centrifuges business and high-quality standards,” said Dr. Peter Fruhstorfer, Co-CEO of Eppendorf AG. “With this acquisition, Eppendorf will become a full-line provider of high-performance premium centrifuges on a global level. This gives us access to new customer groups and offers opportunities for further growth.” The centrifuge business is one of Eppendorf's core businesses, Fruhstorfer continued, which will be sustainably strengthened by the acquisition.

“We are excited to have Eppendorf as a partner in acquiring our Centrifuge & Processing (C&P) business, which has held a first-place business track record in Japan for over 65 years,” said Atsushi Morisawa, CEO of Koki Holdings. “With Eppendorf’s investment through this acquisition, I am sure the Koki-originated C&P business will earn an extraordinary positioning in the global market. With that, Koki Holdings will strategically focus on the power tool industry to become the top brand globally.”

Koki Holdings Co., Ltd., develops and produces ultracentrifuges and floor-standing centrifuges under the brand name himac in Ibaraki Prefecture, Japan, which is north of Tokyo. The parties have agreed not to disclose the purchase price.

Koki Holdings Co., Ltd. was established in 1948 as manufacturer of power tools, including tools used in coal mining. In 1954, Koki began a centrifuge product business that earned a high reputation in the Japanese and global market. Koki Holdings will continue to focus on the power tools business by developing superior products and services aiming to become a leading global company in the industry.

Other news from the department business & finance

These products might interest you

LUMiSizer

LUMiSizer by LUM

The Versatile Particle and Dispersion Analyser: At-Line, in the Process and in the Laboratory

Comprehensive analysis of nano / microparticles & their interactions in dispersions with 1 instrument

nanoparticle analyzers
IKA G-L

IKA G-L by IKA Werke

Sturdy and compact - discover the universal midi centrifuge

Perfect for microfiltration and cell separation

midi centrifuges
Starlab Minizentrifuge

Starlab Minizentrifuge by STARLAB

The Starlab Minicentrifuge - ahead of the curve

This compact unit delivers quiet, intuitive and smooth operation along with a modern design

mini centrifuges
Analytische Ultrazentrifuge (Optima AUC)

Analytische Ultrazentrifuge (Optima AUC) by Beckman Coulter

ideal for characterizing dispersed macromolecules and nanoparticles

combines the power of an ultracentrifuge with the functionality of optical modules

analytical ultracentrifuges
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Loving the sweet enemy - Foods rich in fats and carbohydrates stimulate the reward system in the brain particularly strong

Loving the sweet enemy - Foods rich in fats and carbohydrates stimulate the reward system in the brain particularly strong

First-in-class immunotherapies for the treatment of cancer and autoimmune diseases - ImmunOs Therapeutics Raises $74 Million Series B Financing Round

First-in-class immunotherapies for the treatment of cancer and autoimmune diseases - ImmunOs Therapeutics Raises $74 Million Series B Financing Round

BioMed X and Boehringer Ingelheim start new joint research group

Nobilon advances first vaccine into human trials - Intranasal influenza vaccine begins Phase I clinical development

Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to Merge - Merger to Create NASDAQ-Listed Biopharmaceutical Company named Raptor Pharmaceutical Corp.

Nobel Prize for Physiology or Medicine 2020 Announced - Nobel Prize awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

Nobel Prize for Physiology or Medicine 2020 Announced - Nobel Prize awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

PharmAthene and SIGA Technologies sign definitive merger agreement

PerkinElmer announces third quarter results - GAAP Revenue of $548 million versus $563 million in the comparable prior period

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria - Spin-out from the Universities of Glasgow and Oxford

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria - Spin-out from the Universities of Glasgow and Oxford

Doped by food - Dopamine release regulates our eating behaviour

Doped by food - Dopamine release regulates our eating behaviour

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant - Investment of more than € 140 million creates approximately 55 new jobs

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant - Investment of more than € 140 million creates approximately 55 new jobs